Medicare AdvantageCoverageMedium impact
MA11.066c, Ovarian and Internal Iliac Vein Embolization as Treatment for Pelvic Congestion Syndrome
Independence Blue Cross·Vascular Surgery, Radiology, OB-GYN +1 more·Medical Policy
Effective date
Mar 5, 2025
We identified it
Jun 19, 2026
Summary
Policy MA11.066c addresses coverage for ovarian and internal iliac vein embolization as a treatment for pelvic congestion syndrome, effective March 5, 2025. This is a reissued policy that establishes medical necessity criteria and billing guidelines for this interventional vascular procedure on Medicare Advantage plans.
Action Required
By March 5, 2025: Billing and clinical teams must review policy MA11.066c in detail to identify specific coverage requirements, medical necessity documentation needs, and any prior authorization mandates for ovarian and internal iliac vein embolization procedures. Coordinate with interventional radiology and vascular surgery providers to ensure all claims submitted after the effective date include required supporting documentation. Contact the plan at the source URL or customer service to clarify specific billing codes and prior auth workflows if not explicitly detailed in the full policy text. Update internal compliance tracking to monitor claims for this procedure and ensure adherence to the reissued requirements. Failure to follow coverage criteria may result in claim denials.